2013年考研英语阅读理解精读篇(43)_跨考网
WHAT do you do when everyone hates you? That is the problem faced by America's pharmaceutical industry. Despite its successes in treating disease and extending longevity, soaring health-care costs and bumper profits mean that big drug firms are widely viewed as exploitative, and regarded almost as unfavourably as tobacco and oil firms (see chart). Last week, at a conference organised by The Economist in Philadelphia, the drug industry was offered some advice from an unlikely source: a tobacco firm. Steven Parrish of Altria, the conglomerate that includes Philip Morris, gave his perspective on how an industry can improve its tarnished public image.
Comparing the tobacco and pharmaceutical industries might seem absurd, or even offensive. "Their products kill people. Our products save people's lives," says Alan Holmer, the head of the Pharmaceutical Research and Manufacturers of America, an industry association. Yet the drug giants currently face an unprecedented onslaught of class-action lawsuits and public scrutiny; industry bosses are being grilled by lawmakers asking who knew what and when. It is all reminiscent of what happened to the tobacco industry in 1994.
Mr Parrish advised drug firms to abandon their bunker mentality and engage with their critics. Rather than arguing about the past, he said, it is better to move on, and give people something new to think about. (Philip Morris now acknowledges, for example, that cigarettes are addictive and deadly, and is trying to develop less harmful products.) Not everyone is open to persuasion, so focus on those who are, he said. But changing opinions takes time and demands deeds as well as words: "This is not about spin, this is about change."
The pharmaceutical industry is pursuing a range of initiatives to mollify its critics, Mr Holmer noted in his own speech. But Mr Parrish suggested that speaking with one voice through a trade association might be counter-productive, since it can give the impression that the industry is a monolithic cartel. And too much advertising, he said, can actually antagonise people further.
The audience was generally receptive, claims Mr Parrish. This is not the first time he has offered his thoughts on dealing with implacable critics. At a conference at the University of Michigan last year, he offered America's State Department advice on improving America's image in the Middle East. So does his prescription work? There has been a positive shift in attitudes towards tobacco firms, if only a small one. But at least, for once, a tobacco firm is peddling a cure, rather than a disease.
1.Why is America’s pharmaceutical industry so unpopular?
A. Because it, like tobacco and oil firms, does harm to people’s health and environment.
B. Because it fails to cure disease and make people live longer.
C. Because the prices of its products are too high and its profit margin is too wide.
D. Because it exploits its employees.
2.Alan Holmer is quoted to illustrate that __________.
A. the comparison between tobacco and pharmaceutical industries might seem ridiculous, or even insulting
B. the pharmaceutical industries agree that they are similar to tobacco industry
C. tobacco products do more harm to people than pharmaceutical products
D. pharmaceutical industries are currently facing lots of problems
3.According to the text, Mr. Parrish gives the following suggestions to drug firms except______.
A. To acknowledge the problems and try to do something to improve their images.
B. Not to react to the public in one voice through the drug association.
C. Not to care about the past.
D. To try to spend time and energy to persuade the majority of the audience who are open to persuasion.
4.The word “mollify” (Line 1, Paragraph 4) might mean?
A. placate.
B. enrage.
C. fight.
D. relieve.
5.What does the author imply by saying “This is not the first time he has offered his thoughts on dealing with implacable critics.”?
A. Mr. Parrish has offered his advice to other on dealing with tough critics for several times.
B. Mr. Parrish has dealt successfully with other critics himself.
C. Mr. Parrish has given sound advice to drug firms.
D. Mr. Parrish has been of help to others on critical moments.
2022考研初复试已经接近尾声,考研学子全面进入2023届备考,跨考为23考研的考生准备了10大课包全程准备、全年复习备考计划、目标院校专业辅导、全真复试模拟练习和全程针对性指导;2023考研的小伙伴针也已经开始择校和复习了,跨考考研畅学5.0版本全新升级,无论你在校在家都可以更自如的完成你的考研复习,暑假集训营带来了院校专业初步选择,明确方向;考研备考全年规划,核心知识点入门;个性化制定备考方案,助你赢在起跑线,早出发一点离成功就更近一点!
考研院校专业选择和考研复习计划 | |||
2023备考学习 | 2023线上线下随时学习 | 34所自划线院校考研复试分数线汇总 | |
2022考研复试最全信息整理 | 全国各招生院校考研复试分数线汇总 | ||
2023全日制封闭训练 | 全国各招生院校考研调剂信息汇总 | ||
2023考研先知 | 考研考试科目有哪些? | 如何正确看待考研分数线? | |
不同院校相同专业如何选择更适合自己的 | 从就业说考研如何择专业? | ||
手把手教你如何选专业? | 高校研究生教育各学科门类排行榜 |
相关推荐
跨考考研课程
班型 | 定向班型 | 开班时间 | 高定班 | 标准班 | 课程介绍 | 咨询 |
秋季集训 | 冲刺班 | 9.10-12.20 | 168000 | 24800起 | 小班面授+专业课1对1+专业课定向辅导+协议加强课程(高定班)+专属规划答疑(高定班)+精细化答疑+复试资源(高定班)+复试课包(高定班)+复试指导(高定班)+复试班主任1v1服务(高定班)+复试面授密训(高定班)+复试1v1(高定班) | |
2023集训畅学 | 非定向(政英班/数政英班) | 每月20日 | 22800起(协议班) | 13800起 | 先行阶在线课程+基础阶在线课程+强化阶在线课程+真题阶在线课程+冲刺阶在线课程+专业课针对性一对一课程+班主任全程督学服务+全程规划体系+全程测试体系+全程精细化答疑+择校择专业能力定位体系+全年关键环节指导体系+初试加强课+初试专属服务+复试全科标准班服务 |